


Healthcare Industry News: HIV/AIDS
News Release - June 22, 2020
Cipla Launches CIPREMI (remdesivir Lyophilised Powder for Injection 100 mg), the Only U.S. FDA Approved Emergency Use Authorisation (EUA) Treatment for Patients With Severe COVID-19 Disease
Source: Cipla
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
